Literature DB >> 18700729

Characterization of the microsomal cytochrome P450 2B4 O2 activation intermediates by cryoreduction and electron paramagnetic resonance.

Roman Davydov1, Reza Razeghifard, Sang-Choul Im, Lucy Waskell, Brian M Hoffman.   

Abstract

The oxy-ferrous complex of cytochrome P450 2B4 (2B4) has been prepared at -40 degrees C with and without bound substrate [butylated hydroxytoluene (BHT)] and radiolytically one-electron cryoreduced at 77 K. Electron paramagnetic resonance (EPR) shows that in both cases the observed product of cryoreduction is the hydroperoxo-ferriheme species, indicating that the microsomal P450 contains an efficient distal-pocket proton-delivery network. In the absence of substrate, two distinct hydroperoxo-ferriheme signals are observed, reflecting the presence of two major conformational substates in the oxy-ferrous precursor. Only one species is observed when BHT is bound, indicating a more ordered active site. BHT binding also changes the g-tensor components of the hydroperoxo-ferric 2B4 intermediate, indicating that the substrate modulates the properties of this intermediate. Step annealing the cryoreduced ternary 2B4 complex at >or=175 K causes the loss of hydroperoxo-ferric 2B4 and the parallel appearance of high-spin ferric 2B4; liquid chromatography-tandem mass spectroscopy (LC-MS/MS) analysis shows that in this process BHT is quantitatively converted to two products, hydroxymethyl BHT (1) and 3-hydroxy- tert-butyl BHT (2). This implies that the hydroperoxo-ferric 2B4 prepared by cryoreduction is catalytically active and that the high-spin state observed after annealing contains an enzyme-bound product of BHT monooxygenation. The ratio of products generated during cryoreduction and annealing (6.2/1) is significantly different from the ratio (2.5/1) at ambient temperature. These findings suggest that substrate is held more rigidly relative to the oxidizing species at low temperatures and/or that dissociation of FeOOH is inhibited at low temperature. As in experiments under ambient conditions, product formation is not observed with the inactive F429H 2B4 mutant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700729      PMCID: PMC2709102          DOI: 10.1021/bi800926x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.

Authors:  Haoming Zhang; Larry Gruenke; Dave Arscott; Anna Shen; Charles Kasper; Danni L Harris; Michael Glavanovich; Richard Johnson; Lucy Waskell
Journal:  Biochemistry       Date:  2003-10-14       Impact factor: 3.162

Review 2.  Oxidizing species in the mechanism of cytochrome P450.

Authors:  Paul R Ortiz de Montellano; James J De Voss
Journal:  Nat Prod Rep       Date:  2002-08       Impact factor: 13.423

Review 3.  Multiple oxidants and multiple mechanisms in cytochrome P450 catalysis.

Authors:  Minor J Coon
Journal:  Biochem Biophys Res Commun       Date:  2003-12-05       Impact factor: 3.575

4.  Highly purified microsomal P-450: the oxyferro intermediate stabilized at low temperature.

Authors:  C Bonfils; P Debey; P Maurel
Journal:  Biochem Biophys Res Commun       Date:  1979-06-27       Impact factor: 3.575

5.  Catalytic mechanism of heme oxygenase through EPR and ENDOR of cryoreduced oxy-heme oxygenase and its Asp 140 mutants.

Authors:  Roman Davydov; Viktoria Kofman; Hiroshi Fujii; Tadashi Yoshida; Masao Ikeda-Saito; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2002-02-27       Impact factor: 15.419

6.  Epoxidation of olefins by hydroperoxo-ferric cytochrome P450.

Authors:  Shengxi Jin; Thomas M Makris; Thomas A Bryson; Stephen G Sligar; John H Dawson
Journal:  J Am Chem Soc       Date:  2003-03-26       Impact factor: 15.419

7.  Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding.

Authors:  Emily E Scott; Mark A White; You Ai He; Eric F Johnson; C David Stout; James R Halpert
Journal:  J Biol Chem       Date:  2004-04-20       Impact factor: 5.157

8.  Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin state.

Authors:  Danni L Harris; Jin-Young Park; Larry Gruenke; Lucy Waskell
Journal:  Proteins       Date:  2004-06-01

9.  Conformational substates of the oxyheme centers in alpha and beta subunits of hemoglobin as disclosed by EPR and ENDOR studies of cryoreduced protein.

Authors:  Roman Davydov; Viktoria Kofman; Judith M Nocek; Robert W Noble; Hilda Hui; Brian M Hoffman
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

10.  A superoxo-ferrous state in a reduced oxy-ferrous hemoprotein and model compounds.

Authors:  Roman Davydov; James D Satterlee; Hiroshi Fujii; Alexandra Sauer-Masarwa; Daryle H Busch; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2003-12-31       Impact factor: 15.419

View more
  21 in total

Review 1.  Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Authors:  Piotr J Mak; Ilia G Denisov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-06-28       Impact factor: 3.036

Review 2.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 3.  Reactive intermediates in cytochrome p450 catalysis.

Authors:  Courtney M Krest; Elizabeth L Onderko; Timothy H Yosca; Julio C Calixto; Richard F Karp; Jovan Livada; Jonathan Rittle; Michael T Green
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

4.  Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.

Authors:  Roman Davydov; Sangchoul Im; Muralidharan Shanmugam; William A Gunderson; Naw May Pearl; Brian M Hoffman; Lucy Waskell
Journal:  Biochemistry       Date:  2016-02-03       Impact factor: 3.162

Review 5.  Cytochromes P450 in nanodiscs.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Biochim Biophys Acta       Date:  2010-06-08

6.  Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.

Authors:  Roman Davydov; Andrey A Gilep; Natallia V Strushkevich; Sergey A Usanov; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2012-10-05       Impact factor: 15.419

7.  Comparison of the Mechanisms of Heme Hydroxylation by Heme Oxygenases-1 and -2: Kinetic and Cryoreduction Studies.

Authors:  Roman Davydov; Angela S Fleischhacker; Ireena Bagai; Brian M Hoffman; Stephen W Ragsdale
Journal:  Biochemistry       Date:  2015-12-23       Impact factor: 3.162

8.  Experimental documentation of the structural consequences of hydrogen-bonding interactions to the proximal cysteine of a cytochrome P450.

Authors:  Piotr J Mak; Yuting Yang; Sangchoul Im; Lucy A Waskell; James R Kincaid
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-11       Impact factor: 15.336

9.  The use of deuterated camphor as a substrate in (1)H ENDOR studies of hydroxylation by cryoreduced oxy P450cam provides new evidence of the involvement of compound I.

Authors:  Roman Davydov; John H Dawson; Roshan Perera; Brian M Hoffman
Journal:  Biochemistry       Date:  2013-01-14       Impact factor: 3.162

10.  Arene activation by a nonheme iron(III)-hydroperoxo complex: pathways leading to phenol and ketone products.

Authors:  Abayomi S Faponle; Frédéric Banse; Sam P de Visser
Journal:  J Biol Inorg Chem       Date:  2016-04-20       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.